首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1105254

人重组DNA的全球市场

Human Recombinant DNA: Global Markets

出版日期: 2022年07月21日 | 出版商:

BCC Research | 英文 84 Pages | 订单完成后即时交付

价格

简介目录图表

全球人重组DNA的市场规模，至2022年达到3,487亿美元。

该市场，在2022年～2027年的预测期间内预计以7.3％的年复合成长率扩大，2027年超越4,969亿美元。

本报告提供全球人重组DNA市场相关调查，市场概要，以及各产品类型，各终端用户，各地区趋势，COVID-19影响，及加入此市场的主要企业简介等资讯。

Highlights:

The global human recombinant DNA market should reach $348.7 billion by 2022 and more than $496.9 billion by 2027, with a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2022-2027.

North American human recombinant DNA market should reach $150.8 billion by 2022 and more than $191.7 billion by 2027, with a CAGR of 4.9% during the forecast period of 2022-2027.

Asia-Pacific human recombinant DNA market should reach $86 billion by 2022 and more than $136.2 billion by 2027, with a CAGR of 9.6% during the forecast period of 2022-2027.

Report Scope:

This report highlights the current and future market potential for human recombinant DNA and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, trends and key players in the market. The report also provides market projections from 2022 through 2027. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, and market forces are also provided.

Report Includes:

24 data tables and 8 additional tables
An overview of the global market for human recombinant DNA
Estimation of the market size and analyses of global market trends, with data from 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
Highlights of the market potential for human recombinant DNA, based on product, application, and region
Coverage of history and future of human recombinant DNA, and latest technological advancements of the industry
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
Company profiles of major players within the industry AbbVie Inc., Amgen Inc., Eli Lilly, Sanofi

Chapter 1 Introduction

Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
Scope and Format
Methodology
Market Estimates
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

Homologous Recombination (HR)
Targets for Cancer Therapy

Chapter 4 Impact of COVID-19 Pandemic

Chapter 5 Market Dynamics

Market Drivers
Increasing Incidences of Chronic Diseases
Growing Aging Population
Advancements in Manufacturing Technologies
Market Restraints
Price Controls
Entry of Biosimilars
Opportunities
Untapped Potential in Emerging Markets

Chapter 6 Market Breakdown by Product Type

Human Protein Replacements
Market Size and Forecast
Therapeutic Agents for Human Diseases
Market Size and Forecast
Vaccines
Types of Vaccines
Market Size and Forecast

Chapter 7 Market Breakdown by End User

Biotechnology and Pharmaceutical Industry
Market Size and Forecast
Research Laboratories and Academic Institutes
Market Size and Forecast

Chapter 8 Market Breakdown by Region

Global Market by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 9 Competitive Landscape

Overview

Chapter 10 Company Profiles

ABBVIE INC.
ALEXION PHARMACEUTICALS
AMGEN INC.
ELI LILLY
MERCK & CO. INC.
SANOFI S.A.
TAKEDA PHARMACEUTICAL CO LTD.

简介目录图表

List of Tables

Summary Table : Global Market for Human Recombinant DNA, by Region, Through 2027
Table 1 : Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 2 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 3 : Global Human Recombinant DNA Market, by Product Type, Through 2027
Table 4 : Global Market for Human Protein Replacements, by Region, Through 2027
Table 5 : Global Market for Therapeutic Agents for Human Diseases, by Region, Through 2027
Table 6 : Vaccine Types
Table 7 : Global Market for Vaccines, by Region, Through 2027
Table 8 : Global Market for Human Recombinant DNA, by End User, Through 2027
Table 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, by Region, Through 2027
Table 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, by Region, Through 2027
Table 11 : Global Market for Human Recombinant DNA, by Region, Through 2027
Table 12 : North American Market for Human Recombinant DNA, by Product Type Through 2027
Table 13 : North American Market for Human Recombinant DNA, by End User, Through 2027
Table 14 : North American Market for Human Recombinant DNA, by Country, Through 2027
Table 15 : European Market for Human Recombinant DNA, by Product Type, Through 2027
Table 16 : European Human Recombinant DNA Market, by End User, Through 2027
Table 17 : European Market for Human Recombinant DNA, by Country, Through 2027
Table 18 : Asia-Pacific Market for Human Recombinant DNA, by Product Type, Through 2027
Table 19 : Asia-Pacific Human Recombinant DNA Market, by End User, Through 2027
Table 20 : Asia-Pacific Market for Human Recombinant DNA, by Country, Through 2027
Table 21 : Japan: Total Number of New Cancer Cases in Both Genders, 2020
Table 22 : RoW Market for Human Recombinant DNA, by Product Type, Through 2027
Table 23 : RoW Market for Human Recombinant DNA, by End User, Through 2027
Table 24 : Leading Market Players in the Human Recombinant DNA Market Ecosystem
Table 25 : AbbVie Inc.: Business Segments
Table 26 : AbbVie Inc.: Financial Performance, Through 2020
Table 27 : Amgen: Financial Performance, Through 2020
Table 28 : Eli Lilly: Business Segments
Table 29 : Eli Lilly: Financial Performance, 2018-2020
Table 30 : Sanofi: Business Segments
Table 31 : Sanofi: Financial Performance, 2018-2020

List of Figures

Summary Figure A : Global Market for Human Recombinant DNA, by Region, 2020-2027
Summary Figure B : Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 1 : Global Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 2 : Global Market for Human Recombinant DNA, by Product Type, 2020-2027
Figure 3 : Global Market for Human Protein Replacements, 2020-2027
Figure 4 : Global Market for Therapeutic Agents for Human Diseases, 2020-2027
Figure 5 : Evolution of Vaccine Technologies
Figure 6 : Global Market for Vaccines, 2020-2027
Figure 7 : Global Market Shares of Human Recombinant DNA, by End User, 2021
Figure 8 : Global Market for Human Recombinant DNA, by End User, 2020-2027
Figure 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, 2020-2027
Figure 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, 2020-2027
Figure 11 : Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 12 : North American Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 13 : North American Market Shares of Human Recombinant DNA, by End User, 2021
Figure 14 : North American Market Shares of Human Recombinant DNA, by Country, 2021
Figure 15 : U.S. Market for Human Recombinant DNA, 2020-2027
Figure 16 : Canadian Market for Human Recombinant DNA, 2020-2027
Figure 17 : European Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 18 : European Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 19 : European Market Shares of Human Recombinant DNA, by Country, 2021
Figure 20 : Geriatric Population in Germany, 2000-2030
Figure 21 : German Market for Human Recombinant DNA, 2020-2027
Figure 22 : U.K. Market for Human Recombinant DNA, 2020-2027
Figure 23 : French Market for Human Recombinant DNA, 2020-2027
Figure 24 : Italian Market for Human Recombinant DNA, 2020-2027
Figure 25 : Spanish Market for Human Recombinant DNA, 2020-2027
Figure 26 : Rest of Europe Market for Human Recombinant DNA, 2020-2027
Figure 27 : Asia-Pacific Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 28 : Asia-Pacific Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 29 : Asia-Pacific Market Shares of Human Recombinant DNA, by Country, 2021
Figure 30 : New Cancer Cases in China, 2020
Figure 31 : Distribution of New Cancer Cases in China, 2020
Figure 32 : Chinese Market for Human Recombinant DNA, 2020-2027
Figure 33 : Japanese Market for Human Recombinant DNA, 2020-2027
Figure 34 : Indian Market for Human Recombinant DNA, 2020-2027
Figure 35 : Rest of Asia-Pacific Market for Human Recombinant DNA, 2020-2027
Figure 36 : New Cancer Cases in Africa, 2020
Figure 37 : RoW Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 38 : RoW Market Shares of Human Recombinant DNA, by End User, 2021
Figure 39 : AbbVie Inc.: Net Revenue, by Business Segment, 2020
Figure 40 : AbbVie Inc.: Net Revenue, by Region, 2020
Figure 41 : Amgen: Total Sales, by Product, 2020
Figure 42 : Amgen: Total Revenue, by Region, 2020
Figure 43 : Eli Lilly: Total Sales, by Product Segment, 2020
Figure 44 : Eli Lilly: Total Revenue, by Region, 2020
Figure 45 : Sanofi: Net Sales, by Business Segment, 2020
Figure 46 : Sanofi: Net Sales, by Region, 2020

02-2729-4219

+886-2-2729-4219

License/价格

人重组DNA的全球市场

Human Recombinant DNA: Global Markets

目录

第1章简介

第2章彙整和亮点

第3章概要

第4章 COVID-19大流行的影响

第5章市场动态

第6章市场明细，各产品类型

第7章市场明细，各终端用户

第8章市场明细，各地区

第9章竞争情形

第10章企业简介